Phibro Animal Health (PAHC) Upgraded to “Sell” at BidaskClub
Phibro Animal Health (NASDAQ:PAHC) was upgraded by equities researchers at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued to investors on Saturday.
Several other equities research analysts have also weighed in on PAHC. Zacks Investment Research lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Wednesday, November 1st. ValuEngine lowered Phibro Animal Health from a “buy” rating to a “hold” rating in a research report on Thursday, November 9th. Finally, Piper Jaffray Companies restated a “buy” rating and set a $42.00 price target on shares of Phibro Animal Health in a research report on Friday, November 10th. Three research analysts have rated the stock with a sell rating, one has issued a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $38.25.
Phibro Animal Health (NASDAQ PAHC) traded up $0.45 during midday trading on Friday, hitting $35.30. The company had a trading volume of 59,097 shares, compared to its average volume of 114,340. The company has a quick ratio of 1.85, a current ratio of 3.26 and a debt-to-equity ratio of 1.91. Phibro Animal Health has a one year low of $26.10 and a one year high of $40.25. The company has a market capitalization of $1,400.38, a price-to-earnings ratio of 20.76, a PEG ratio of 4.07 and a beta of 1.27.
Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings results on Monday, November 6th. The company reported $0.38 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.01. Phibro Animal Health had a return on equity of 42.75% and a net margin of 8.87%. The company had revenue of $193.40 million for the quarter, compared to analyst estimates of $189.89 million. During the same period in the previous year, the company posted $0.36 earnings per share. The firm’s revenue was up 2.9% on a year-over-year basis. research analysts predict that Phibro Animal Health will post 1.57 EPS for the current year.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Algert Global LLC raised its stake in Phibro Animal Health by 18.8% during the third quarter. Algert Global LLC now owns 79,802 shares of the company’s stock valued at $2,957,000 after buying an additional 12,647 shares during the last quarter. California Public Employees Retirement System raised its stake in Phibro Animal Health by 9.5% during the third quarter. California Public Employees Retirement System now owns 44,994 shares of the company’s stock valued at $1,667,000 after buying an additional 3,894 shares during the last quarter. U S Global Investors Inc. purchased a new position in Phibro Animal Health during the third quarter valued at $1,071,000. Cornerstone Capital Management Holdings LLC. raised its stake in Phibro Animal Health by 7.5% during the third quarter. Cornerstone Capital Management Holdings LLC. now owns 127,421 shares of the company’s stock valued at $4,720,000 after buying an additional 8,900 shares during the last quarter. Finally, Magnetar Financial LLC purchased a new position in Phibro Animal Health during the third quarter valued at $605,000. Institutional investors own 48.42% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece was published by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://www.watchlistnews.com/phibro-animal-health-pahc-upgraded-to-sell-at-bidaskclub/1797633.html.
About Phibro Animal Health
Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with Analyst Ratings Network's FREE daily email newsletter.